File Download

  • Find it @ UNIST can give you direct access to the published full text of this article. (UNISTARs only)
Related Researcher

박종남

Park, Jongnam
Materials and Chemistry Lab.
Read More

Views & Downloads

Detailed Information

Cited time in webofscience Cited time in scopus
Metadata Downloads

Charge-Modulated Synthesis of Highly Stable Iron Oxide Nanoparticles for In Vitro and In Vivo Toxicity Evaluation

Author(s)
Woo, SunyoungKim, SoojinKim, HyunhongCheon, Young WooYoon, SeokjooOh, Jung-HwaPark, Jongnam
Issued Date
2021-11
DOI
10.3390/nano11113068
URI
https://scholarworks.unist.ac.kr/handle/201301/58700
Fulltext
https://www.mdpi.com/2079-4991/11/11/3068
Citation
NANOMATERIALS, v.11, no.11, pp.3068
Abstract
The surface charge of iron oxide nanoparticles (IONPs) plays a critical role in the interactions between nanoparticles and biological components, which significantly affects their toxicity in vitro and in vivo. In this study, we synthesized three differently charged IONPs (negative, neutral, and positive) based on catechol-derived dopamine, polyethylene glycol, carboxylic acid, and amine groups, via reversible addition–fragmentation chain transfer-mediated polymerization (RAFT polymerization) and ligand exchange. The zeta potentials of the negative, neutral, and positive IONPs were −39, −0.6, and +32 mV, respectively, and all three IONPs showed long-term colloidal stability for three months in an aqueous solution without agglomeration. The cytotoxicity of the IONPs was studied by analyzing cell viability and morphological alteration in three human cell lines, A549, Huh-7, and SH-SY5Y. Neither IONP caused significant cellular damage in any of the three cell lines. Furthermore, the IONPs showed no acute toxicity in BALB/c mice, in hematological and histological analyses. These results indicate that our charged IONPs, having high colloidal stability and biocompatibility, are viable for bio-applications
Publisher
MDPI
ISSN
2079-4991

qrcode

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.